Position in IONS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$299,183,489
+$50,078,046 QoQ
Shares Held
3,984,332
+26.5% QoQ
Ownership
2.41%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IONS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. IONS ranks #11 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in IONS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $299,183,489 | 3,984,332 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $249,105,443 | 3,148,849 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $200,596,625 | 3,066,289 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $114,227,163 | 2,891,095 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $85,771,921 | 2,842,954 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $93,946,189 | 2,687,248 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $106,894,420 | 2,668,358 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $118,413,366 | 2,484,544 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $102,490,497 | 2,364,256 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $115,139,349 | 2,275,931 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $99,552,998 | 2,194,731 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $88,496,294 | 2,156,868 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $73,980,013 | 2,069,950 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $76,020,547 | 2,012,723 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $84,087,554 | 1,901,143 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $69,047,223 | 1,865,133 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $70,283,103 | 1,897,492 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $55,541,627 | 1,825,226 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $59,458,605 | 1,772,767 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $70,307,720 | 1,762,540 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $77,742,404 | 1,729,146 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $94,546,414 | 1,672,204 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $75,459,449 | 1,590,294 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $90,431,963 | 1,533,785 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $70,497,553 | 1,491,065 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||